Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.
- NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_assertion description "[The trifunctional carbamoylphosphate synthetase/aspartate transcarbamyltransferase/dihydroorotase (CAD) gene is hormone responsive in MCF-7 and ZR-75 breast cancer cells, and this response is inhibited by the aryl hydrocarbon receptor (AhR) agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.
- NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_assertion evidence source_evidence_literature NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.
- NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_assertion SIO_000772 16675542 NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.
- NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_assertion wasDerivedFrom befree-20150227 NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.
- NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_assertion wasGeneratedBy ECO_0000203 NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.
- befree-20150227 importedOn "2015-02-27" NP968420.RAktpYoWW_BRQSaiJ87WcV3IRqLqW5gumgOsB1xE_qavs130_provenance.